Question 270
The risk owner says a control improvement is complete: A project manager removes security validation from the schedule to recover delays but retains an unchanged risk rating. What outcome would most clearly demonstrate its effectiveness?
Explanation
Correct Answer
The revised project decision reflects reduced assurance and approved treatment. This demonstrates the intended business or control result, rather than just task completion. The underlying response was: Reassess and escalate the release risk before approving schedule recovery options. The evidence should relate to: Review changes to project scope, assurance coverage and residual release exposure.
Incorrect Answers
The program demonstrates consistent consent decisions across both product lines. That would matter when two agile teams both build customer consent components without coordination, producing conflicting permission records. The relevant distinction in this case is: The revised project decision reflects reduced assurance and approved treatment.
The approved portfolio explains why mandatory and high-exposure investments receive priority. That would matter when a portfolio board funds multiple security projects solely by project ROI, ignoring shared dependencies and risk appetite. It does not address this case's requirement: A project manager removes security validation from the schedule to recover delays but retains an unchanged risk rating.
Integration records show authorized interfaces and owners with controlled deprecation plans. That would matter when an organization adds dozens of tactical integrations that bypass its approved architecture review process. That separate mechanism does not verify the needed risk management outcome in this case.